Skip to search formSkip to main contentSkip to account menu

ocular hypotensive

Known as: antiglaucoma drug 
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

Colforsin
Glaucoma

Broader (1)

OPHTHALMIC AGENTS

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Chrontherapeutic drug delivery system of antiglaucoma drug forskolin
Chronotherapeutic refers to a treatment method in which in vivo drug availability is timed to match rhythms of disease in order… 
2014
2014
LABORATORY INVESTIGATION : Regeneration of optic nerve fibers with unoprostone, a prostaglandin-related antiglaucoma drug, in adult cats
2014
2014
EVALUATION OF OCULOHYPOTENSIVE EFFECT OF ENALAPRILAT USING INTRAOCULAR PRESSURE (IOP) RECOVERY MODEL IN RABBITS
The present study was designed to evaluate the oculohypotensive effect of enalaprilat in comparison to timolol using an… 
2011
2011
Effects of Topical Nipradilol on Early Diabetic Retinopathy in SDT Rats
We tested the effect of topical nipradilol, an antiglaucoma drug with �- and �-blocker and nitric oxide (NO) donor activities, on… 
2001
2001
항녹내장 약제 점안 후 눈물분비와 눈물막 안정성의 변화
Purpose : To investigate the changes in tear flow and tear filim stability in patients with long-term instillation of… 
1998
1998
[A new Russian combined antihypertensive preparation proxopheline in the treatment of glaucoma].
Tolerance and efficacy of a new combined antiglaucoma drug proxopheline (1% proxodolol and 0.25% clopheline) is assessed. Studies… 
1998
1998
[The creation of original Russian beta-adrenoblockers].
Results of search for new beta-adrenoreceptor blocking agents of different effects are summarized. Derivatives of 4… 
1998
1998
[Prospects of using latanoprost, prostaglandin F2 alpha analog, in hypotensive therapy for glaucoma].
Hypotensive efficacy and tolerance of a new antiglaucoma drug lathanoprost, a 0.005% xalathane solution, prostaglandin F2 alpha… 
1997
1997
Hornhautsensibilitätsveränderung nach topischer Dorzolamidapplikation Vergleichende Studie
Background: The new antiglaucoma drug, dorzolamide, mainly evokes local side effects like eye burning, pruritus, blurred sight… 
1991
1991
[Clinical evaluation of the hypotensive effectiveness of Betoptic preparation].
Clinical trials of the hypotensive effect of 0.5% betoptic, an antiglaucoma drug manufactured by Alcon (USA), were carried out at… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)